Adage Capital Partners Gp, L.L.C. Karyopharm Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 4,319,842 shares of KPTI stock, worth $3.67 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,319,842
Previous 3,500,000
23.42%
Holding current value
$3.67 Million
Previous $5.29 Million
28.89%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding KPTI
# of Institutions
115Shares Held
64.9MCall Options Held
500KPut Options Held
99K-
Vanguard Group Inc Valley Forge, PA7.65MShares$6.51 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$4.34 Million0.56% of portfolio
-
Eversept Partners, LP New York, NY4.99MShares$4.24 Million0.33% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$3.54 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.1MShares$2.64 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $67.8M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...